INDAPTUS THERAPEUTICS INC (INDP:NASDAQ)
$2.77 0.14 (5.3232%)
Analysed INDAPTUS THERAPEUTICS INC (INDP:NASDAQ) News Sources
Indaptus Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
13-08-2025
yahoo.com
Indaptus Therapeutics to Present at the H.C. Wainwright 27ᵗʰ Annual Global Investment Conference
02-09-2025
yahoo.com
Indaptus Therapeutics Provides Clinical Update
04-09-2025
yahoo.com
Wall Street Set to Open Higher Friday; Nonfarm Payrolls Fall Well Short of Forecasts
05-09-2025
yahoo.com
Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
12-11-2025
yahoo.com
Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit
17-11-2025
yahoo.com
Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
29-12-2025
yahoo.com
Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
15-05-2026
yahoo.com
What is the current price of INDAPTUS THERAPEUTICS INC (INDP:NASDAQ)?
The current price of INDAPTUS THERAPEUTICS INC (INDP:NASDAQ) is $2.77.
INDAPTUS THERAPEUTICS INC (INDP:NASDAQ) absolute price change since previous trading day?
The absolute price change of INDAPTUS THERAPEUTICS INC (INDP:NASDAQ) since the previous trading day is $0.14.
INDAPTUS THERAPEUTICS INC (INDP:NASDAQ) percentage price change since previous trading day?
The percentage price change of INDAPTUS THERAPEUTICS INC (INDP:NASDAQ) since the previous trading day is 5.3232%.
What is the most recent average sentiment score for INDAPTUS THERAPEUTICS INC (INDP:NASDAQ)?
The most recent average sentiment score for INDAPTUS THERAPEUTICS INC (INDP:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for INDAPTUS THERAPEUTICS INC (INDP:NASDAQ)?
The most recent sentiment for INDAPTUS THERAPEUTICS INC (INDP:NASDAQ) is .
SEC-8K** Filing Available For INDAPTUS THERAPEUTICS INC (INDP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.